b2a9c13d-6552-82d2-e053-2a95a90acad4

SPL v1

SPL

SPL Set ID b2a9c13d-6552-82d2-e053-2a95a90acad4

Route

oral

Published

Effective Date 2020-10-15

Document Type 34390-5 HUMAN OTC DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients

potassium phosphate, unspecified form (3 [hp_X])

Inactive Ingredients

lactose monohydrate

Identifiers & Packaging

Pill Appearance

Imprint: SBL Shape: round Color: white Size: 6 mm Score: 1

Marketing Status

unapproved homeopathic active Since 2020-11-10

Description

Kali Phos 3X

Medication Information

Warnings and Precautions

Stop use and ask doctor if symptoms worsen or persist longer than 7 days.

Do not use if tamper evident seal is missing or broken.

Active Ingredient

Kali Phos 3X

Indications and Usage

Temporary relief fatigue, weakness, exhaustion.

Dosage and Administration

Adults and children 12 years of age and older: Four tablets every thirty minutes for six doses followed by four tablets every 4-6 hours as needed.

Children 2 years to 12 years of age: Four tablets every thirty minutes for six doses followed by two tablets every 4-6 hours as needed.

Children under 2 years of age: Consult doctor prior to use.

Description

Kali Phos 3X

Section 50565-1

Keep out of reach of children.

Section 51727-6

Lactose

Section 51945-4

Section 55105-1

Temporary relief fatigue, weakness, exhaustion.

Structured Label Content

Warnings and Precautions (34071-1)

Stop use and ask doctor if symptoms worsen or persist longer than 7 days.

Do not use if tamper evident seal is missing or broken.

Active Ingredient (55106-9)

Kali Phos 3X

Indications and Usage (34067-9)

Temporary relief fatigue, weakness, exhaustion.

Dosage and Administration (34068-7)

Adults and children 12 years of age and older: Four tablets every thirty minutes for six doses followed by four tablets every 4-6 hours as needed.

Children 2 years to 12 years of age: Four tablets every thirty minutes for six doses followed by two tablets every 4-6 hours as needed.

Children under 2 years of age: Consult doctor prior to use.

Section 50565-1 (50565-1)

Keep out of reach of children.

Section 51727-6 (51727-6)

Lactose

Section 51945-4 (51945-4)

Section 55105-1 (55105-1)

Temporary relief fatigue, weakness, exhaustion.

Advanced Ingredient Data

[{"name": "LACTOSE MONOHYDRATE", "unii": "EWQ57Q8I5X", "classCode": "IACT", "strengthNumerator": "", "strengthDenominator": "", "strengthNumeratorUnit": "", "strengthDenominatorUnit": ""}, {"name": "POTASSIUM PHOSPHATE, UNSPECIFIED FORM", "unii": "B7862WZ632", "classCode": "ACTIB", "strengthNumerator": "3", "strengthDenominator": "1", "strengthNumeratorUnit": "[hp_X]", "strengthDenominatorUnit": "1"}]

Raw Label Data

All Sections (JSON)

{"34067-9": "Temporary relief fatigue, weakness, exhaustion.", "34068-7": "Adults and children 12 years of age and older: Four tablets every thirty minutes for six doses followed by four tablets every 4-6 hours as needed. Children 2 years to 12 years of age: Four tablets every thirty minutes for six doses followed by two tablets every 4-6 hours as needed. Children under 2 years of age: Consult doctor prior to use.", "34071-1": "Stop use and ask doctor if symptoms worsen or persist longer than 7 days. Do not use if tamper evident seal is missing or broken.", "50565-1": "Keep out of reach of children.", "51727-6": "Lactose", "55105-1": "Temporary relief fatigue, weakness, exhaustion.", "55106-9": "Kali Phos 3X"}

Additional Information

Back to search View SPL set listing Open on DailyMed ↗

Source: dailymed · Ingested: 2026-02-15T12:09:55.788799 · Updated: 2026-03-14T23:14:58.948891